Senator John Fetterman, a democrat from Pennsylvania, admitted to using weight loss drug Mounjaro and issued a desperate plea ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability issue of obesity medications such as Wegovy and Zepbound.

About half of Americans "strongly" or "somewhat" favor having Medicare and Medicaid cover weight-loss drugs for people who ...

Senator John Fetterman, a democrat from Pennsylvania, admitted to using weight loss drug Mounjaro and issued a desperate plea ...

In the ever-evolving landscape of healthcare, telemedicine has emerged as a transformative force, providing individuals with ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

LongeVC, an international investor based in Latvia, has injected an unspecified sum into Cambridge company Constructive Bio ...

Nurx, a leading telehealth platform specializing in women's health, is excited to announce an integration agreement with Gifthealth, Eli Lilly and Company's LillyDirect® pharmacy provider, for ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Maintaining health and wellness can be daunting in today’s fast-paced world. Many individuals struggle with weight management, sexual wellness, and overall well-being. Enter JRNYS, a telemedicine ...

I RECEIVED a letter from CVS Caremark informing me that effective March 1st, HealthTrust would no longer cover anti-obesity ...